The healthcare sector, proxied by the XLV ETF, moved higher driven by strong quarterly earnings reports from key constituents Eli Lilly (LLY) and CVS Health (CVS). [3] Both companies beat analyst expectations and raised their full-year guidance for 2026, boosting investor confidence in the sector's profitability. [3, 17] This news comes amid a broader positive sentiment shift, with investors showing renewed appetite for healthcare stocks due to improving earnings and attractive valuations. [7, 10]